On July 30, 2020 Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon), reported that they will present the corporate overview at the ACCESS CHINA Forum 2020, Summer Online Partnering Day, hosted by YAFO Capital Life Science (Press release, Genenta Science, JUL 30, 2020, View Source [SID1234568503]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pierluigi Paracchi, Founder, Chairman and CEO of Genenta, will present the immune-gene therapy technology for tumors treatment, ongoing clinical trials, and company’s strategy on July 31, at 11:30am CET